Dapiprazole

Dapiprazole
Clinical data

AHFS/Drugs.com	Consumer Drug Information
MedlinePlus	a601043
Pregnancy category	B
Routes of administration	Topical (eye drops)
ATC code	S01EX02 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	Negligible when administered topically
Identifiers
IUPAC name 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8- tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
CAS Number	72822-12-9^Y
PubChem CID	3033538
IUPHAR/BPS	7155
DrugBank	DB00298^Y
ChemSpider	2298190^Y
UNII	5RNZ8GJO7K
KEGG	D07775^Y
ChEBI	CHEBI:51066^Y
ChEMBL	CHEMBL1201216^N
Chemical and physical data
Formula	C₁₉H₂₇N₅
Molar mass	325.451 g/mol
3D model (Jmol)	Interactive image
SMILES n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
InChI InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3^Y Key:RFWZESUMWJKKRN-UHFFFAOYSA-N^Y
^NY (what is this?)

Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.